Spherix Global Insights Announces Special Coverage of Amgen's Amjevita Launch, Tracking Uptake and Perceptions of the First Commercially-available Biosimilar to AbbVie's Humira

/PRNewswire/ -- AbbVie's Humira (adalimumab) is the world's best selling drug, but the entry of biosimilar challengers, with Amgen's Amjevita being the first...

Related Keywords

United States ,Amgen Amjevita ,Amgen Avsola ,Coheru Yusimry ,Scott Upham ,July Boehringer Ingelheim Cyltezo ,Abbvie Humira ,Chrystal Ferguson ,Merck Renflexis ,Amgen ,Linkedin ,Twitter ,Corporate Communications ,Spherix Network ,Special Topix ,Biosimilars Today ,Boehringer Ingelheim ,Global Insights ,Spherix Global Insights ,Global Insights Contacts ,Insights Director ,